Comments
Loading...

HeartSciences Analyst Ratings

HSCSNASDAQ
Logo brought to you by Benzinga Data
$2.47
-0.08-3.14%
At close: Dec 15, 4:00 PM EST
$2.40
-0.07-2.83%
After Hours: 5:14 PM EST
Q2 2026 earnings were released today after the market close
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$3.30
Consensus Price Target1
$8.10

HeartSciences Analyst Ratings and Price Targets | NASDAQ:HSCS | Benzinga

HeartSciences Inc has a consensus price target of $8.1 based on the ratings of 3 analysts. The high is $12 issued by Maxim Group on December 18, 2024. The low is $3.3 issued by Ascendiant Capital on January 30, 2023. The 3 most-recent analyst ratings were released by Ascendiant Capital, Ascendiant Capital, and Maxim Group on October 1, 2025, March 18, 2025, and December 18, 2024, respectively. With an average price target of $11.67 between Ascendiant Capital, Ascendiant Capital, and Maxim Group, there's an implied 386.11% upside for HeartSciences Inc from these most-recent analyst ratings.

Analyst Trends and Forecast

1
Oct
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Ascendiant Capital
Maxim Group
Ascendiant Capital

1calculated from analyst ratings

Analyst Ratings for HeartSciences

Get Alert
Oct 1, 2025
275%
9
15
Previous
Buy
Current
Buy
Get Alert
Mar 18, 2025
483.33%
14
15
Previous
Buy
Current
Buy
Get Alert
Dec 18, 2024
400%
12
12
Previous
Buy
Current
Buy
Get Alert
Sep 23, 2024
525%
15
15
Previous
Buy
Current
Buy
Get Alert
Jan 30, 2023
37.5%
3.3
Previous
Initiates
Current
Buy
Get Alert
Dec 19, 2022
25%
3
8
Previous
Current
Buy
Get Alert

FAQ

Q

What is the target price for HeartSciences (HSCS) stock?

A

The latest price target for HeartSciences (NASDAQ:HSCS) was reported by Ascendiant Capital on October 1, 2025. The analyst firm set a price target for $9.00 expecting HSCS to rise to within 12 months (a possible 275.00% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for HeartSciences (HSCS)?

A

The latest analyst rating for HeartSciences (NASDAQ:HSCS) was provided by Ascendiant Capital, and HeartSciences maintained their buy rating.

Q

When was the last upgrade for HeartSciences (HSCS)?

A

There is no last upgrade for HeartSciences

Q

When was the last downgrade for HeartSciences (HSCS)?

A

There is no last downgrade for HeartSciences.

Q

When is the next analyst rating going to be posted or updated for HeartSciences (HSCS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of HeartSciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for HeartSciences was filed on October 1, 2025 so you should expect the next rating to be made available sometime around October 1, 2026.

Q

Is the Analyst Rating HeartSciences (HSCS) correct?

A

While ratings are subjective and will change, the latest HeartSciences (HSCS) rating was a maintained with a price target of $15.00 to $9.00. The current price HeartSciences (HSCS) is trading at is $2.40, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.